Heritable disorders of the bile ducts

Gastroenterology Clinics of North America

Volumn 32, Issue 3, 2003, Pages 857-875

  Kamath, Binita M ^a   Piccoli, David A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BILE ACID; BILIRUBIN; COLESTYRAMINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR ALPHA; GAMMA GLUTAMYLTRANSFERASE; MEDIUM CHAIN TRIACYLGLYCEROL; NOTCH RECEPTOR; REGULATOR PROTEIN; RIFAMPICIN; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ALAGILLE SYNDROME; AUTOSOMAL DOMINANT DISORDER; BILE DUCT ATRESIA; BILE DUCT DISEASE; CELL DIFFERENTIATION; CLINICAL FEATURE; COMMON BILE DUCT CYST; DIET THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GENE; GENE MUTATION; GENETIC DISORDER; HUMAN; INTRAHEPATIC BILE DUCT; JAG1 GENE; JAUNDICE; KIDNEY POLYCYSTIC DISEASE; LABORATORY DIAGNOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; PHENOTYPE; PKHD1 GENE; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PROGNOSIS; PRURITUS; REVIEW; SCLEROTHERAPY; SIGNAL TRANSDUCTION;

EID: 0141459607     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(03)00054-2     Document Type: Review

References (68)

1. Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme "ductal plate malformation." Hepatology 1992;16(4):1069-83.
2. Jorgensen MJ. The ductal plate malformation. Acta Pathol Microbiol Scand 1977; (Suppl 257):1-87.
3. Bernstein J. Hepatic involvement in hereditary renal syndromes. Birth Defects Orig Artic Ser 1987;23(1):115-30.
4. Zerres K, Rudnik-Schoneborn S, Deget F, Holtkamp U, Brodehl J, Geisert J, et al. Autosomal recessive polycystic kidney disease in 115 children: clinical presentation, course and influence of gender. Arbeitsgemeinschaft fur Padiatrische, Nephrologie. Acta Paediatr 1996;85(4):437-45.
5. Bergmann C, Senderek J, Sedlacek B, Pegiazoglou I, Puglia P, Eggermann T, et al. Spectrum of Mutations in the Gene for Autosomal Recessive Polycystic Kidney Disease (ARPKD/PKHD 1). J Am Soc Nephrol 2003;14(1):76-89.
6. Lieberman E, Salinas-Madrigal L, Gwinn JL, Brennan LP, Fine RN, Landing BH. Infantile polycystic disease of the kidneys and liver: clinical, pathological and radiological correlations and comparison with congenital hepatic fibrosis. Medicine [Baltimore] 1971;50(4):277-318.
7. Richards WG, Sweeney WE, Yoder BK, Wilkinson JE, Woychik RP, Avner ED. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J Clin Invest 1998;101(5):935-9.
8. Nauta J, Ozawa Y, Sweeney WE Jr, Rutledge JC, Avner ED. Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease. Pediatr Nephrol 1993;7(2):163-72.
9. Nauta J, Sweeney WE, Rutledge JC, Avner ED. Biliary epithelial cells from mice with congenital polycystic kidney disease are hyperresponsive to epidermal growth factor. Pediatr Res 1995;37(6):755-63.
10. Sweeney WE, Chen Y, Nakanishi K, Frost P, Avner ED. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int 2000;57(1):33-40.
11. Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 2002;30(3):259-69.
12. Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet 2002;70(5):1305-17.
13. Blyth H, Ockenden BG. Polycystic disease of kidney and liver presenting in childhood. J Med Genet 1971;8(3):257-84.
14. Guay-Woodford LM, Galliani CA, Musulman-Mroczek E, Spear GS, Guillot AP, Bernstein J. Diffuse renal cystic disease in children: morphologic and genetic correlations. Pediatr Nephrol 1998;12(3):173-82.
15. Roy S, Dillon MJ, Trompeter RS, Barratt TM. Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors. Pediatr Nephrol 1997;11(3):302-6.
16. Alvarez F, Hadchouel M, Bernard O. Latent chronic cholangitis in congenital hepatic fibrosis. Eur J Pediatr 1982;139(3):203-5.
17. Kerr DN, Okonkwo S, Choa RG. Congenital hepatic fibrosis: the long-term prognosis. Gut 1978;19(6):514-20.
18. Anand SK, Chan JC, Lieberman E. Polycystic disease and hepatic fibrosis in children. Renal function studies. Am J Dis Child 1975;129(7):810-3.
19. Alvarez F, Bernard O, Brunelle F, Hadchouel M, Leblanc A, Odievre M, et al. Congenital hepatic fibrosis in children. J Pediatr 1981;99(3):370-5.
20. Fiorillo A, Migliorati R, Vajro P, Caldore M, Vecchione R. Congenital hepatic fibrosis with gastrointestinal bleeding in early infancy. Clin Pediatr [Phila] 1982;21(3):183-5.
21. Odievre M, Chaumont P, Montagne JP, Alagille D. Anomalies of the intrahepatic portal venous system in congenital hepatic fibrosis. Radiology 1977;122(2):427-30.
22. Jung G, Benz-Bohm G, Kugel H, Keller KM, Querfeld U. MR cholangiography in children with autosomal recessive polycystic kidney disease. Pediatr Radiol 1999;29(6):463-6.
23. Murray-Lyon IM, Shilkin KB, Laws JW, Illing RC, Williams R. Non-obstructive dilatation of the intrahepatic biliary tree with cholangitis. Q J Med 1972;41(164):477-89.
24. Howlett SA, Shulman ST, Ayoub EM, Alexander RA, Donnelly WH, Cerda JJ. Cholangitis complicating congenital hepatic fibrosis. Am J Dig Dis 1975;20(8):790-5.
25. Murray-Lyon IA, Shilkin KB, Laws JW, Illing RC, Williams R. Cholangitis complicating congenital hepatic fibrosis. Gut 1972;13(4):319.
26. Sanchez C, Gonzalez E, Garau J. Trimethoprim-sulfamethoxazole treatment of cholangitis complicating congenital hepatic fibrosis. Pediatr Infect Dis 1986;5(3):360-3.
27. Naveh Y, Roguin N, Ludatscher R, Auslaender L, Schramek A, Aharon M. Congenital hepatic fibrosis with congenital heart disease. A family study with ultrastructural features of the liver. Gut 1980;21(9):799-807.
28. Neumann HP, Krumme B, van Velthoven V, Orszagh M, Zerres K. Multiple intracranial aneurysms in a patient with autosomal recessive polycystic kidney disease. Nephrol Dial Transplant 1999;14(4):936-9.
29. King K, Genta RM, Giannella RA, Weesner RE. Congenital hepatic fibrosis and cerebral aneurysm in a 32-year-old woman. J Pediatr Gastroenterol Nutr 1986;5(3):481-4.
30. Dusol Jr M, Levi JU, Glasser K, Schiff ER. Congenital hepatic fibrosis with dilation of intrahepatic bile ducts. A therapeutic approach. Gastroenterology 1976;71(5):839-43.
31. Grunfeld JP, Albouze G, Jungers P, Landais P, Dana A, Droz D, et al. Liver changes and complications in adult polycystic kidney disease. Adv Nephrol Necker Hosp 1985;14:1-20.
32. Kissane JM. Congenital Malformations. In: Heptinstall RH, editor. Pathology of the Kidney. 2nd edition. Boston: Little Brown and Co; 1974. p. 69.
33. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995;10(2):151-60.
34. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. The International Polycystic Kidney Disease Consortium. Cell 1995;81(2):289-98.
35. Gallagher AR, Hidaka S, Gretz N, Witzgall R. Molecular basis of autosomal-dominant polycystic kidney disease. Cell Mol Life Sci 2002;59(4):682-93.
36. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996;272(5266):1339-42.
37. Daoust MC, Reynolds DM, Bichet DG, Somlo S. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 1995;25(3):733-6.
38. Landing BH, Wells TR, Claireaux AE. Morphometric analysis of liver lesions in cystic diseases of childhood. Hum Pathol 1980;11(Suppl 5):549-60.
39. Bernstein J, Stickler GB, Neel IV. Congenital hepatic fibrosis: evolving morphology. APMIS Suppl 1988;4:17-26.
40. Alagille D, Odievre M, Gautier M, Dommergues JP. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J Pediatr 1975;86(1):63-71.
41. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997;16(3):243-51.
42. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997;16(3):235-42.
43. Emerick KM, Rand EB, Goldmuntz E, Krantz ID, Spinner NB, Piccoli DA. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology 1999;29(3):822-9.
44. Lykavieris P, Hadchouel M, Chardot C, Bernard O. Outcome of liver disease in children with Alagille syndrome: a study of 163 patients. Gut 2001;49(3):431-5.
45. Emerick KM, Whitington PF. Clinical aspects of familial cholestasis (with molecular explanations). Curr Gastroenterol Rep 1999;1(3):223-30.
46. Kamath BM, Krantz ID, Spinner NB, Heubi JE, Piccoli DA. Monozygotic twins with a severe form of Alagille syndrome and phenotypic discordance. Am J Med Genet 2002;112(2):194-7.
47. Krantz ID, Piccoli DA, Spinner NB. Clinical and molecular genetics of Alagille syndrome. Curr Opin Pediatr 1999;11(6):558-64.
48. Krantz ID, Colliton RP, Genin A, Rand EB, Li L, Piccoli DA, et al. Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. Am J Hum Genet 1998;62(6):1361-9.
49. Eldadah ZA, Hamosh A, Biery NJ, Montgomery RA, Duke M, Elkins R, et al. Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. Hum Mol Genet 2001;10(2):163-9.
50. Krantz ID, Rand EB, Genin A, Hunt P, Jones M, Louis AA, et al. Deletions of 20p12 in Alagille syndrome: frequency and molecular characterization. Am J Med Genet 1997;70(1):80-6.
51. Silberbach M, Lashley D, Reller MD, Kinn WF Jr, Terry A, Sunderland CO. Arteriohepatic dysplasia and cardiovascular malformations. Am Heart J 1994;127(3):695-9.
52. Crosnier C, Lykavieris P, Meunier-Rotival M, Hadchouel M. Alagille syndrome. The widening spectrum of arteriohepatic dysplasia. Clin Liver Dis 2000;4(4):765-78.
53. Sokol RJ, Heubi JE, Balistreri WF. Intrahepatic "cholestasis facies": is it specific for Alagille syndrome? J Pediatr 1983;103(2):205-8.
54. Kamath BM, Loomes KM, Oakey RJ, Emerick KE, Conversano T, Spinner NB, et al. Facial features in Alagille syndrome: Specific or cholestasis facies? Am J Med Genet 2002;112(2):163-70.
55. Alagille D, Estrada A, Hadchouel M, Gautier M, Odievre M, Dommergues JP. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr 1987;110(2):195-200.
56. Watson GH, Miller V. Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease. Arch Dis Child 1973;48(6):459-66.
57. Berard E, Sarles J, Triolo V, Gagnadoux MF, Wernert F, Hadchouel M, et al. Renovascular hypertension and vascular anomalies in Alagille syndrome. Pediatr Nephrol 1998;12(2):121-4.
58. Connor SE, Hewes D, Ball C, Jarosz JM. Alagille syndrome associated with angiographic moyamoya. Childs Nerv Syst 2002;18(3-4):186-90.
59. Quek SC, Tan L, Quek ST, Yip W, Aw M, Quak SH. Abdominal coarctation and Alagille syndrome. Pediatrics 2000;106(1):E9.
60. Shefler AG, Chan MK, Ostman-Smith I. Middle aortic syndrome in a boy with arteriohepatic dysplasia (Alagille syndrome). Pediatr Cardiol 1997;18(3):232-4.
61. Hoffenberg EJ, Narkewicz MR, Sondheimer JM, Smith DJ, Silverman A, Sokol RJ. Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J Pediatr 1995;127(2):220-4.
62. Berard E, Triolo V. Intracranial hemorrhages in Alagille syndrome. J Pediatr 2000;136(5):708-10.
63. Moreau S, Bourdon N, Jokic M, de Rugy MG, Babin E, Valdazo A, et al. Alagille syndrome with cavernous carotid artery aneurysm. Int J Pediatr Otorhinolaryngol 1999;50(2):139-43.
64. Woolfenden AR, Albers GW, Steinberg GK, Hahn JS, Johnston DC, Farrell K. Moyamoya syndrome in children with Alagille syndrome: additional evidence of a vasculopathy. Pediatrics 1999;103(2):505-8.
65. Emerick KM, Whitington PF. Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome. Hepatology 2002;35(6):1501-6.
66. Tzakis AG, Reyes J, Tepetes K, Tzoracoleftherakis V, Todo S, Starzl TE. Liver transplantation for Alagille's syndrome. Arch Surg 1993;128(3):337-9.
67. Cardona J, Houssin D, Gauthier F, Devictor D, Losay J, Hadchouel M, et al. Liver transplantation in children with Alagille syndrome-a study of twelve cases. Transplantation 1995;60(4):339-42.
68. Gurkan A, Emre S, Fishbein TM, Brady L, Millis M, Birnbaum A, et al. Unsuspected bile duct paucity in donors for living-related liver transplantation: two case reports. Transplantation 1999;67(3):416-8.